Abstract
Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by extreme lack of body fat and severe insulin resistance since birth. Recently, mutations have been reported in 1-acylglycerol-3-phosphate-O-acyltransferase 2 (AGPAT2) and Berardinelli–Seip congenital lipodystrophy 2 (BSCL2 or Seipin) genes in affected subjects from pedigrees linked to chromosomes 9q34 and 11q13, respectively. The AGPAT2 catalyses the acylation of the lysophosphatidic acid at the sn-2 position to form phosphatidic acid, a key intermediate in the biosynthesis of triacylglycerol and glycerophospholipids. High expression of AGPAT2 mRNA in adipose tissue compared to other isoforms suggests that the mutations might affect the adipose tissue the most. The function of BSCL2 remains unknown. Several CGL pedigrees reveal no mutation in either of the above genes and are not linked to these loci, suggesting additional genetic loci for CGL. Thus, several distinct mechanisms can lead to extreme lack of adipose tissue in humans and cause CGL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Seip M, Trygstad O . Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 1996; 413: 2–28.
Garg A . Lipodystrophies. Am J Med 2000; 108: 143–152.
Garg A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F, Kocak N, O'Rahilly S, Taylor SI, Patel SB, Bowcock AM . A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 1999; 84: 3390–3394.
Magre J, Delepine M, Khallouf E, Gedde-Dahl Jr T, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O'Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J . Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001; 28: 365–370.
Agarwal AK, Arioglu E, de Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A . AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 2002; 31: 21–23.
Magre J, Delepine M, Van Maldergem L, Robert JJ, Maassen JA, Meier M, Panz VR, Kim CA, Tubiana-Rufi N, Czernichow P, Seemanova E, Buchanan CR, Lacombe D, Vigouroux C, Lascols O, Kahn CR, Capeau J, Lathrop M . Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 2003; 52: 1573–1578.
Fu M, Kazlauskaite R, Baracho MDF, Santos MR, Neto JB, Villares S, Celi F, Wajchenberg B, Shuldiner AR . Mutations in Gng3lg and AGPAT2 in Berardinelli–Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects (abstract). Diabetes 2003; 52 (Suppl 1): A250.
Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, Zaidi Z, Gurakan F, Arslanian SA, Klar A, Ricker A, White NH, L B, Herbst K, Kennel K, Patel SB, Al-Gazali L, Garg A . Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab 2003; 88: 4840–4847.
Eberhardt C, Gray PW, Tjoelker LW . Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3. J Biol Chem 1997; 272: 20299–20305.
Lewin TM, Wang P, Coleman RA . Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry 1999; 38: 5764–5771.
Leung DW . The structure and functions of human lysophosphatidic acid acyltransferases. Front Biosci 2001; 6: d944–d953.
Turnbull AP, Rafferty JB, Sedelnikova SE, Slabas AR, Schierer TP, Kroon JT, Simon JW, Fawcett T, Nishida I, Murata N, Rice DW . Analysis of the structure, substrate specificity, and mechanism of squash glycerol-3-phosphate (1)-acyltransferase. Structure (Camb) 2001; 9: 347–353.
Eberhardt C, Gray PW, Tjoelker LW . cDNA cloning, expression and chromosomal localization of two human lysophosphatidic acid acyltransferases. Adv Exper Med Biol 1999; 469: 351–356.
Agarwal AK, Garg A . Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab 2003; 14: 214–221.
Pages C, Simon MF, Valet P, Saulnier-Blache JS . Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediators 2001; 64: 1–10.
Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ . Lysophospholipids—receptor revelations. Science 2001; 294: 1875–1878.
Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese Jr RV . Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 2000; 25: 87–90.
Hammond LE, Gallagher PA, Wang S, Hiller S, Kluckman KD, Posey-Marcos EL, Maeda N, Coleman RA . Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 2002; 22: 8204–8214.
Van Maldergem L, Magre J, Khallouf TE, Gedde-Dahl Jr T, Delepine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Megarbane A, Maassen J, Polak M, Lacombe D, Kahn CR, Silveira EL, D'Abronzo FH, Grigorescu F, Lathrop M, Capeau J, O'Rahilly S . Genotype–phenotype relationships in Berardinelli–Seip congenital lipodystrophy. J Med Genet 2002; 39: 722–733.
Heathcote K, Rajab A, Magre J, Syrris P, Besti M, Patton M, Delepine M, Lathrop M, Capeau J, Jeffery S . Molecular analysis of Berardinelli–Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes 2002; 51: 1291–1293.
Acknowledgements
We thank A Osborn, RG Huet and R Butsch for illustrations and technical assistance. The study was supported by the National Institute of Health grants, R01-DK54387 and M01-RR00633, and by the Southwestern Medical Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agarwal, A., Barnes, R. & Garg, A. Genetic basis of congenital generalized lipodystrophy. Int J Obes 28, 336–339 (2004). https://doi.org/10.1038/sj.ijo.0802487
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802487
Keywords
This article is cited by
-
Principles and functions of metabolic compartmentalization
Nature Metabolism (2022)
-
New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Protein & Cell (2018)
-
Occurrence of plastidial triacylglycerol synthesis and the potential regulatory role of AGPAT in the model diatom Phaeodactylum tricornutum
Biotechnology for Biofuels (2017)
-
Familial partial lipodystrophy, Dunnigan variety - challenges for patient care during pregnancy: a case report
BMC Research Notes (2015)
-
Congenital generalized lipodystrophies—new insights into metabolic dysfunction
Nature Reviews Endocrinology (2015)